Literature DB >> 25368239

Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.

Takanobu Masuda1, Yuichiro Nakashima2, Koji Ando2, Keiji Yoshinaga2, Hiroshi Saeki2, Eiji Oki2, Masaru Morita2, Yoshinao Oda3, Yoshihiko Maehara2.   

Abstract

BACKGROUND: The CXCL12/CXCR4 axis plays a pivotal role in cancer progression and metastases in various epithelial cancer cells. The aim of the present study was to evaluate the localization and correlation between CXCL12/CXCR4 expression and clinicopathological features in gastric cancers.
MATERIALS AND METHODS: This study included 111 Japanese patients with primary gastric cancers, which invade submucosa or more, all of whom underwent gastrectomy between 1992 and 1996. Immunohistochemical analysis was performed.
RESULTS: A significant correlation was found in the immunoreactivity of nuclear CXCR4 and poor differentiation (p=0.0026), infiltrated pattern (p<0.0001), larger size (p<0.0001), advanced stage (p=0.0342) and reduced 5-year survival rate (30% vs. 61%, p=0.0012). Multivariate analysis revealed that high nuclear CXCR4 immunoreactivity (RR: 3.077, p=0.0329) retained its strength as an independent prognostic factor for overall survival.
CONCLUSION: High immunoreactivity of nuclear CXCR4 in gastric cancer suggests that CXCL12 binds to its unique receptor CXCR4 at the membrane, translocates to the nucleus and then becomes more invasive, and thus can be considered a prognostic factor. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  CXCL12; immunohistochemistry; translocation

Mesh:

Substances:

Year:  2014        PMID: 25368239

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.

Authors:  Teresa San-Miguel; Sandra Pinto; Lara Navarro; Robert C Callaghan; Carlos Monteagudo; Concha López-Ginés; Miguel Cerdá-Nicolás; Rosario Gil-Benso
Journal:  Pathol Oncol Res       Date:  2015-06-03       Impact factor: 3.201

Review 2.  Chemokines and their receptors as biomarkers in esophageal cancer.

Authors:  Masakazu Goto; Mingyao Liu
Journal:  Esophagus       Date:  2019-11-26       Impact factor: 4.230

3.  All in for nuclear PFKP-induced CXCR4 metastasis: a T cell acute lymphoblastic leukemia prognostic marker.

Authors:  Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

4.  C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.

Authors:  Hongyan Mo; Qinyu Wu; Jinhua Miao; Congwei Luo; Xue Hong; Yongping Wang; Lan Tang; Fan Fan Hou; Youhua Liu; Lili Zhou
Journal:  Antioxid Redox Signal       Date:  2017-03-28       Impact factor: 8.401

Review 5.  Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma.

Authors:  Li-Jun Xue; Xiao-Bei Mao; Li-Li Ren; Xiao-Yuan Chu
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

6.  A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosis.

Authors:  Manchao Kuang; Jieyao Cheng; Chengli Zhang; Lin Feng; Xue Xu; Yajing Zhang; Ming Zu; Jianfang Cui; Hang Yu; Kaitai Zhang; Aiming Yang; Shujun Cheng
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

Review 7.  Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases.

Authors:  Salomé Gonçalves-Monteiro; Rita Ribeiro-Oliveira; Maria Sofia Vieira-Rocha; Martin Vojtek; Joana B Sousa; Carmen Diniz
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-07

8.  In the ovine pituitary, CXCR4 is localized in gonadotropes and somatotropes and increases with elevated serum progesterone.

Authors:  N S Sanchez; K E Quinn; A K Ashley; R L Ashley
Journal:  Domest Anim Endocrinol       Date:  2017-10-28       Impact factor: 2.566

9.  CXCR4-expressing Mist1+ progenitors in the gastric antrum contribute to gastric cancer development.

Authors:  Kosuke Sakitani; Yoku Hayakawa; Huan Deng; Hiroshi Ariyama; Hiroto Kinoshita; Mitsuru Konishi; Satoshi Ono; Nobumi Suzuki; Sozaburo Ihara; Zhengchuan Niu; Woosook Kim; Takayuki Tanaka; Haibo Liu; Xiaowei Chen; Yagnesh Tailor; James G Fox; Stephen F Konieczny; Hiroshi Onodera; Antonia R Sepulveda; Samuel Asfaha; Yoshihiro Hirata; Daniel L Worthley; Kazuhiko Koike; Timothy C Wang
Journal:  Oncotarget       Date:  2017-11-10

10.  CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells.

Authors:  Meng Wang; Tie Lin; Yicun Wang; Song Gao; Zhaoyang Yang; Xuan Hong; Gongyan Chen
Journal:  Onco Targets Ther       Date:  2017-06-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.